drugset / Trial / NCT02482818

Efficacy of Pregabalin on Chronic Cough

NCT02482818

Phase 1/2 Unknown 40 enrolled Ottawa Hospital Research Institute
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine if Pregabalin, a medication used for the treatment of seizures and chronic pain, can be used to effectively treat people who suffer from non-asthmatic chronic cough (cough lasting over 8 weeks).

Timeline

Start
2015-09
Primary completion
2021-12-31
Completion
2021-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule 100 mg

Indications

No indication recorded.